Anika Therapeutics Inc (ANIK)
17.43
+0.25
(+1.46%)
USD |
NASDAQ |
Nov 21, 16:00
17.44
+0.01
(+0.06%)
After-Hours: 20:00
Anika Therapeutics Gross Profit Margin (Quarterly): 3.72% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.72% |
| June 30, 2024 | 65.28% |
| March 31, 2024 | 60.78% |
| December 31, 2023 | 61.27% |
| September 30, 2023 | 60.16% |
| June 30, 2023 | 65.40% |
| March 31, 2023 | 60.23% |
| December 31, 2022 | 60.90% |
| September 30, 2022 | 56.57% |
| June 30, 2022 | 62.69% |
| March 31, 2022 | 59.42% |
| December 31, 2021 | 50.62% |
| September 30, 2021 | 58.23% |
| June 30, 2021 | 54.56% |
| March 31, 2021 | 61.16% |
| December 31, 2020 | 51.22% |
| September 30, 2020 | 54.72% |
| June 30, 2020 | 44.79% |
| March 31, 2020 | 59.88% |
| December 31, 2019 | 70.95% |
| September 30, 2019 | 79.96% |
| June 30, 2019 | 77.53% |
| March 31, 2019 | 70.43% |
| December 31, 2018 | 74.03% |
| September 30, 2018 | 69.08% |
| Date | Value |
|---|---|
| June 30, 2018 | 73.31% |
| March 31, 2018 | 63.11% |
| December 31, 2017 | 70.34% |
| September 30, 2017 | 77.01% |
| June 30, 2017 | 81.13% |
| March 31, 2017 | 73.99% |
| December 31, 2016 | 73.76% |
| September 30, 2016 | 80.62% |
| June 30, 2016 | 77.18% |
| March 31, 2016 | 75.65% |
| December 31, 2015 | 79.64% |
| September 30, 2015 | 78.14% |
| June 30, 2015 | 76.97% |
| March 31, 2015 | 72.21% |
| December 31, 2014 | 76.30% |
| September 30, 2014 | 74.04% |
| June 30, 2014 | 79.70% |
| March 31, 2014 | 87.18% |
| December 31, 2013 | 70.66% |
| September 30, 2013 | 69.71% |
| June 30, 2013 | 69.70% |
| March 31, 2013 | 68.25% |
| December 31, 2012 | 67.84% |
| September 30, 2012 | 51.10% |
| June 30, 2012 | 58.81% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
3.72%
Minimum
Sep 2024
70.95%
Maximum
Dec 2019
56.13%
Average
60.02%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 78.34% |
| Xtant Medical Holdings Inc | 58.37% |
| Myomo Inc | 75.43% |
| Catheter Precision Inc | 89.58% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -45.09% |
| Return on Assets | -35.94% |
| Return on Invested Capital | -45.09% |
| Profit Margin (Quarterly) | -77.20% |
| Operating Margin (Quarterly) | -64.29% |
| Return on Net Operating Assets | -54.86% |